Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance

Inovio Pharmaceuticals IncTrade
Tripadvisor Inc Common StockTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Tripadvisor Inc Common Stock — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Tripadvisor Inc Common Stock trades at $13.82 (market cap $1.68B). The key difference: Tripadvisor Inc Common Stock is far larger — about 18.8× Inovio Pharmaceuticals Inc's market cap, and Tripadvisor Inc Common Stock is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

INOTRIP
Market Cap
$89.27M$1.68B
Sector
HealthConsumer Cyclical
52-Week High
$2.87$19.14
52-Week Low
$1.05$9.24
Enterprise Value
$60.28M$1.80B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO

About Tripadvisor Inc Common Stock

TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).

Read more on TRIP